THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 319933
INDIANAPOLIS, IN
Position in VRTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$31,291
+$3,161 QoQ
Shares Held
63
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,535
of 1,705 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. holds $361,152 across 14 Biotechnology names. VRTX ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,637 | $89,271 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
236 | $74,588 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
254 | $61,194 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
1,067 | $36,160 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
63 | $31,291 | |
| 6 | RPRX |
Royalty Pharma plc
|
393 | $22,035 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
455 | $16,102 | |
| 8 | MRNA |
Moderna, Inc.
|
145 | $10,153 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,291 | 63 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $28,130 | 63 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $34,453 | 76 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $93,982 | 240 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,213,974 | 2,727 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,053,906 | 2,174 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $712,309 | 1,769 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $509,685 | 1,096 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $431,644 | 921 | Shares | Sole | 2024-07-05 | |
| No filing history on record for this holder in this stock. | ||||||